Evidence map›Paper›PMID 15107833›Full record

ArticleOncogene2004

Drosophila Src-family kinases function with Csk to regulate cell proliferation and apoptosis.

Laura G Pedraza, Rodney A Stewart, Da-Ming Li, Tian Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Apoptosis regulation by the tyrosine-protein kinase CSK.Frontiers in cell and developmental biology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. A Gene Expression Screen inG3 (Bethesda, Md.) · 2019
    Article
  14. International journal of molecular sciences · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Adherens Junction and E-Cadherin complex regulation by epithelial polarity.Cellular and molecular life sciences : CMLS · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Laura G PedrazaDepartment of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, Boyer Center for Molecular Medicine, 295 Congress Avenue, PO Box 9812, New Haven, CT 06536-0812, USA.
Rodney A Stewart
Da-Ming Li
Tian Xu
Dana-Farber Cancer Institute · USHoward Hughes Medical Institute · USYale University · US

Funding

TUMOR SUPPRESSORS AND CELL PROLIFERATION IN DROSOPHILAR01CA069408 · NCI · YALE UNIVERSITY · PI XU, TIAN · 1996 to 2016
$5.1M
NCI NIH HHS CA69408
6 · The paper itself

Abstract

Elevated Src protein levels and activity are associated with the development and progression of a variety of cancers. The consequences of deregulated Src activity have been studied extensively in cell culture; however, the effects of this deregulation in vivo, as well as the mechanisms of Src-induced tumorigenesis, remain poorly understood. In this study, the effect of expressing wild-type and constitutively active Drosophila Src-family kinases (SFKs) in the developing eye was examined. Overexpression of either wild-type Drosophila SFK (Src64 and Src42) is sufficient to induce ectopic proliferation in G1/G0-arrested, uncommitted cells in eye imaginal discs. In addition, both kinases trigger apoptosis in vivo, in a dosage-dependent manner. Constitutively active mutants are hypermorphic as they trigger proliferation and death more potently than their wild-type counterparts. Moreover, SFK-induced proliferation and apoptosis are largely independent events, as blocking ectopic proliferation does not block cell death. Further, DCsk (the Drosophila homolog of the C-terminal Src kinase) phosphorylates and interacts genetically with the wild-type SFKs, but not with the constitutively active mutants in which a conserved C-terminal tyrosine was mutated to phenylalanine, providing the first in vivo evidence that Csk regulates SFKs during development through phosphorylation of their C-terminal tyrosine.

Indexed as

ApoptosisAnimalsCell DivisionCloning, MolecularCSK Tyrosine-Protein KinaseDrosophilaDrosophila ProteinsEnzyme ActivationEyeGlutathione TransferaseLarvaMembrane ProteinsMicroscopy, Electron, ScanningMutationPhosphoproteinsRecombinant Fusion ProteinsCsk protein, DrosophilaCSK Tyrosine-Protein KinaseDrosophila ProteinsGlutathione TransferaseMembrane ProteinsPhosphoproteinsRecombinant Fusion Proteinssrc-Family Kinases

Identifiers

PMID15107833
OpenAlexW2046010877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.